In March 2019, Novo Nordisk Research Centre China (NNRCC) launched INNOVO^®, an open innovation platform, as we gear up for increased research collaborations with dynamic innovation forces in China, building a new pharmaceutical innovation ecosystem and contributing to research pipelines locally and globally. 

By far, INNOVO^® has established diverse partnerships among universities, biotech companies, hospitals, research institutes and consortium etc, spanning a number of areas, such as diabetes, obesity, CVD, NASH, AI in drug research and other novel technologies.